Back to Search Start Over

Targeting adenylate-forming enzymes with designed sulfonyladenosine inhibitors.

Authors :
Lux MC
Standke LC
Tan DS
Source :
The Journal of antibiotics [J Antibiot (Tokyo)] 2019 Jun; Vol. 72 (6), pp. 325-349. Date of Electronic Publication: 2019 Apr 15.
Publication Year :
2019

Abstract

Adenylate-forming enzymes are a mechanistic superfamily that are involved in diverse biochemical pathways. They catalyze ATP-dependent activation of carboxylic acid substrates as reactive acyl adenylate (acyl-AMP) intermediates and subsequent coupling to various nucleophiles to generate ester, thioester, and amide products. Inspired by natural products, acyl sulfonyladenosines (acyl-AMS) that mimic the tightly bound acyl-AMP reaction intermediates have been developed as potent inhibitors of adenylate-forming enzymes. This simple yet powerful inhibitor design platform has provided a wide range of biological probes as well as several therapeutic lead compounds. Herein, we provide an overview of the nine structural classes of adenylate-forming enzymes and examples of acyl-AMS inhibitors that have been developed for each.

Details

Language :
English
ISSN :
1881-1469
Volume :
72
Issue :
6
Database :
MEDLINE
Journal :
The Journal of antibiotics
Publication Type :
Academic Journal
Accession number :
30982830
Full Text :
https://doi.org/10.1038/s41429-019-0171-2